Clinical Microbiology Market By Product (Laboratory Instruments, Automated Culture System, Reagents) , By Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 300 pages | ID: C530D18A851EEN
Allied Market Research

Abstracts

Clinical Microbiology Market Expected to Garner $9.7 Billion by 2033, Growing at a CAGR of 7.5%

Abstract: The global clinical microbiology market is expected to grow primarily due to the growing healthcare-associated infections (HAIs) and rising demand for accurate testing solutions. The North America region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global clinical microbiology market was valued at $4.8 billion in 2023 and is expected to register a revenue of $9.7 billion by 2033 at a CAGR of 7.5% during the forecast period 2024-2033.

Dynamics of the Market

The increasing healthcare-associated infections (HAIs), rising adoption of molecular diagnostic techniques, and the growing demand for rapid & accurate testing solutions are expected to make the clinical microbiology market a highly profitable one in the forecast period. Besides, the growing emphasis on personalized medicine is predicted to drive the market growth.

However, according to market analysts, stringent regulatory requirements for product approval and limited access to testing facilities might restrain the growth of the market.

Advances in clinical microbiology technologies and innovations in automated microbial identification & susceptibility testing systems present significant opportunities for clinical microbiology market growth. Moreover, expansion of healthcare facilities in developing regions is expected to further boost the market growth in the coming years.

Key Players of the Market

The major players of the clinical microbiology market include Becton, Dickinson and Company, Thermo Fisher Scientific, bioMйrieux SA, Bio-Rad Laboratories, Bruker Corporation, Hoffmann-La Roche AG, Danaher Corporation, Hologic, and Abbott Laboratories.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Analysis of raw material in a product (by %)
• Investment Opportunities
• Technology Trend Analysis
• Consumer Preference and Product Specifications
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Strategic Recommendations
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• List of customers/consumers/raw material suppliers- value chain analysis
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Product

• Laboratory Instruments
• Automated Culture System
• Reagents

By Disease

• Respiratory Diseases
• Bloodstream Infections
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Russia
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Malaysia
• Indonesia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Argentina
• Rest of LAMEA
• Key Market Players
• BD
• Hardy Diagnostics, Inc.
• BioMerieux SA
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• F. HOFFMANN-LA ROCHE AG
• Bruker Corporation
• Danaher Corporation
• Abbott Laboratories
• Hologic

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Product
4.2. Laboratory Instruments
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Automated Culture System
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Reagents
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country

CHAPTER 5: CLINICAL MICROBIOLOGY MARKET, BY DISEASE

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Disease
5.2. Respiratory Diseases
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Bloodstream Infections
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Gastrointestinal Diseases
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country
5.5. Sexually Transmitted Diseases
  5.5.1. Key Market Trends, Growth Factors and Opportunities
  5.5.2. Market Size and Forecast, By Region
  5.5.3. Market Share Analysis, By Country
5.6. Urinary Tract Infections
  5.6.1. Key Market Trends, Growth Factors and Opportunities
  5.6.2. Market Size and Forecast, By Region
  5.6.3. Market Share Analysis, By Country
5.7. Periodontal Diseases
  5.7.1. Key Market Trends, Growth Factors and Opportunities
  5.7.2. Market Size and Forecast, By Region
  5.7.3. Market Share Analysis, By Country
5.8. Others
  5.8.1. Key Market Trends, Growth Factors and Opportunities
  5.8.2. Market Size and Forecast, By Region
  5.8.3. Market Share Analysis, By Country

CHAPTER 6: CLINICAL MICROBIOLOGY MARKET, BY REGION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Region
6.2. North America
  6.2.1. Key Market Trends and Opportunities
  6.2.2. Market Size and Forecast, By Product
  6.2.3. Market Size and Forecast, By Disease
  6.2.4. Market Size and Forecast, By Country
  6.2.5. U.S. Clinical Microbiology Market
    6.2.5.1. Market Size and Forecast, By Product
    6.2.5.2. Market Size and Forecast, By Disease
  6.2.6. Canada Clinical Microbiology Market
    6.2.6.1. Market Size and Forecast, By Product
    6.2.6.2. Market Size and Forecast, By Disease
  6.2.7. Mexico Clinical Microbiology Market
    6.2.7.1. Market Size and Forecast, By Product
    6.2.7.2. Market Size and Forecast, By Disease
6.3. Europe
  6.3.1. Key Market Trends and Opportunities
  6.3.2. Market Size and Forecast, By Product
  6.3.3. Market Size and Forecast, By Disease
  6.3.4. Market Size and Forecast, By Country
  6.3.5. France Clinical Microbiology Market
    6.3.5.1. Market Size and Forecast, By Product
    6.3.5.2. Market Size and Forecast, By Disease
  6.3.6. Germany Clinical Microbiology Market
    6.3.6.1. Market Size and Forecast, By Product
    6.3.6.2. Market Size and Forecast, By Disease
  6.3.7. Italy Clinical Microbiology Market
    6.3.7.1. Market Size and Forecast, By Product
    6.3.7.2. Market Size and Forecast, By Disease
  6.3.8. Spain Clinical Microbiology Market
    6.3.8.1. Market Size and Forecast, By Product
    6.3.8.2. Market Size and Forecast, By Disease
  6.3.9. UK Clinical Microbiology Market
    6.3.9.1. Market Size and Forecast, By Product
    6.3.9.2. Market Size and Forecast, By Disease
  6.3.10. Russia Clinical Microbiology Market
    6.3.10.1. Market Size and Forecast, By Product
    6.3.10.2. Market Size and Forecast, By Disease
  6.3.11. Rest Of Europe Clinical Microbiology Market
    6.3.11.1. Market Size and Forecast, By Product
    6.3.11.2. Market Size and Forecast, By Disease
6.4. Asia-Pacific
  6.4.1. Key Market Trends and Opportunities
  6.4.2. Market Size and Forecast, By Product
  6.4.3. Market Size and Forecast, By Disease
  6.4.4. Market Size and Forecast, By Country
  6.4.5. China Clinical Microbiology Market
    6.4.5.1. Market Size and Forecast, By Product
    6.4.5.2. Market Size and Forecast, By Disease
  6.4.6. Japan Clinical Microbiology Market
    6.4.6.1. Market Size and Forecast, By Product
    6.4.6.2. Market Size and Forecast, By Disease
  6.4.7. India Clinical Microbiology Market
    6.4.7.1. Market Size and Forecast, By Product
    6.4.7.2. Market Size and Forecast, By Disease
  6.4.8. South Korea Clinical Microbiology Market
    6.4.8.1. Market Size and Forecast, By Product
    6.4.8.2. Market Size and Forecast, By Disease
  6.4.9. Australia Clinical Microbiology Market
    6.4.9.1. Market Size and Forecast, By Product
    6.4.9.2. Market Size and Forecast, By Disease
  6.4.10. Thailand Clinical Microbiology Market
    6.4.10.1. Market Size and Forecast, By Product
    6.4.10.2. Market Size and Forecast, By Disease
  6.4.11. Malaysia Clinical Microbiology Market
    6.4.11.1. Market Size and Forecast, By Product
    6.4.11.2. Market Size and Forecast, By Disease
  6.4.12. Indonesia Clinical Microbiology Market
    6.4.12.1. Market Size and Forecast, By Product
    6.4.12.2. Market Size and Forecast, By Disease
  6.4.13. Rest of Asia-Pacific Clinical Microbiology Market
    6.4.13.1. Market Size and Forecast, By Product
    6.4.13.2. Market Size and Forecast, By Disease
6.5. LAMEA
  6.5.1. Key Market Trends and Opportunities
  6.5.2. Market Size and Forecast, By Product
  6.5.3. Market Size and Forecast, By Disease
  6.5.4. Market Size and Forecast, By Country
  6.5.5. Brazil Clinical Microbiology Market
    6.5.5.1. Market Size and Forecast, By Product
    6.5.5.2. Market Size and Forecast, By Disease
  6.5.6. South Africa Clinical Microbiology Market
    6.5.6.1. Market Size and Forecast, By Product
    6.5.6.2. Market Size and Forecast, By Disease
  6.5.7. Saudi Arabia Clinical Microbiology Market
    6.5.7.1. Market Size and Forecast, By Product
    6.5.7.2. Market Size and Forecast, By Disease
  6.5.8. UAE Clinical Microbiology Market
    6.5.8.1. Market Size and Forecast, By Product
    6.5.8.2. Market Size and Forecast, By Disease
  6.5.9. Argentina Clinical Microbiology Market
    6.5.9.1. Market Size and Forecast, By Product
    6.5.9.2. Market Size and Forecast, By Disease
  6.5.10. Rest of LAMEA Clinical Microbiology Market
    6.5.10.1. Market Size and Forecast, By Product
    6.5.10.2. Market Size and Forecast, By Disease

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. BD
  8.1.1. Company Overview
  8.1.2. Key Executives
  8.1.3. Company Snapshot
  8.1.4. Operating Business Segments
  8.1.5. Product Portfolio
  8.1.6. Business Performance
  8.1.7. Key Strategic Moves and Developments
8.2. Hardy Diagnostics, Inc.
  8.2.1. Company Overview
  8.2.2. Key Executives
  8.2.3. Company Snapshot
  8.2.4. Operating Business Segments
  8.2.5. Product Portfolio
  8.2.6. Business Performance
  8.2.7. Key Strategic Moves and Developments
8.3. BioMerieux SA
  8.3.1. Company Overview
  8.3.2. Key Executives
  8.3.3. Company Snapshot
  8.3.4. Operating Business Segments
  8.3.5. Product Portfolio
  8.3.6. Business Performance
  8.3.7. Key Strategic Moves and Developments
8.4. Thermo Fisher Scientific Inc.
  8.4.1. Company Overview
  8.4.2. Key Executives
  8.4.3. Company Snapshot
  8.4.4. Operating Business Segments
  8.4.5. Product Portfolio
  8.4.6. Business Performance
  8.4.7. Key Strategic Moves and Developments
8.5. Bio-Rad Laboratories
  8.5.1. Company Overview
  8.5.2. Key Executives
  8.5.3. Company Snapshot
  8.5.4. Operating Business Segments
  8.5.5. Product Portfolio
  8.5.6. Business Performance
  8.5.7. Key Strategic Moves and Developments
8.6. F. HOFFMANN-LA ROCHE AG
  8.6.1. Company Overview
  8.6.2. Key Executives
  8.6.3. Company Snapshot
  8.6.4. Operating Business Segments
  8.6.5. Product Portfolio
  8.6.6. Business Performance
  8.6.7. Key Strategic Moves and Developments
8.7. Bruker Corporation
  8.7.1. Company Overview
  8.7.2. Key Executives
  8.7.3. Company Snapshot
  8.7.4. Operating Business Segments
  8.7.5. Product Portfolio
  8.7.6. Business Performance
  8.7.7. Key Strategic Moves and Developments
8.8. Danaher Corporation
  8.8.1. Company Overview
  8.8.2. Key Executives
  8.8.3. Company Snapshot
  8.8.4. Operating Business Segments
  8.8.5. Product Portfolio
  8.8.6. Business Performance
  8.8.7. Key Strategic Moves and Developments
8.9. Abbott Laboratories
  8.9.1. Company Overview
  8.9.2. Key Executives
  8.9.3. Company Snapshot
  8.9.4. Operating Business Segments
  8.9.5. Product Portfolio
  8.9.6. Business Performance
  8.9.7. Key Strategic Moves and Developments
8.10. Hologic
  8.10.1. Company Overview
  8.10.2. Key Executives
  8.10.3. Company Snapshot
  8.10.4. Operating Business Segments
  8.10.5. Product Portfolio
  8.10.6. Business Performance
  8.10.7. Key Strategic Moves and Developments